Theodore Scott Nowicki MD
Pediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology
Physician
Join to View Full Profile
200 UCLA Medical PlzSte 265Los Angeles, CA 90095
Phone+1 310-825-0867
Fax+1 310-206-4855
Dr. Nowicki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Theodore Nowicki is a pediatric hematologist/oncologist in Los Angeles, CA and is affiliated with Ronald Reagan UCLA Medical Center. He received his medical degree from New York Medical College and has been in practice 4 years. He specializes in pediatric sarcoma oncology and pediatric solid tumor oncology.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Hematology/Oncology, 2016 - 2019- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 2013 - 2016
New York Medical CollegeClass of 2013
Certifications & Licensure
CA State Medical License 2014 - 2028
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer Start of enrollment: 2017 Jul 26
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 3 citationsTNF-alpha: Roles in pathogenesis and therapeutics in cancer.Miriam Valenzuela Cardenas, Theodore Scott Nowicki
The Journal of Biological Chemistry. 2026-03-01 - 1 citationsHuman cancer-targeted immunity via transgenic hematopoietic stem cell progeny.Theodore S Nowicki, Nataly Naser Al Deen, Cole W Peters, Begoña Comin-Anduix, Egmidio Medina
Nature Communications. 2025-07-01 - 6 citationsSelpercatinib prior to radioactive iodine for pediatric papillary thyroid carcinoma.Harvey K Chiu, Theodore S Nowicki, Masha J Livhits, James X Wu, Noah Federman
Journal of Pediatric Endocrinology & Metabolism. 2024-11-26
Journal Articles
- Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-cell PopulationsZeynep Eroglu, Iman Osman, Theodore S Nowicki, Antoni Ribas, Michael A Davies, Farbod Darvishian, Daniel Y Wang, Douglas B Johnson, Ravi K Amaravadi, Clinical Cancer Research
Press Mentions
Breakthrough Stem Cell Therapy Could Provide Permanent Cancer ImmunitySeptember 20th, 2025
UCLA Researchers Engineer Stem Cells to Generate Renewable Cancer-Fighting T CellsAugust 4th, 2025
HMN 2025: How Scientists Reprogram Stem Cells to Create Renewable Cancer-Fighting T CellsJuly 31st, 2025
Grant Support
- TNF-alpha-"armed" TCR vectors to enhance adoptive cell therapy for solid tumorsUNIVERSITY OF CALIFORNIA LOS ANGELES2025–2030
- Functional epigenomics of transgenic cellular immunotherapies for cancerUNIVERSITY OF CALIFORNIA LOS ANGELES2021–2026
- Functional epigenomics of transgenic cellular immunotherapies for cancerUNIVERSITY OF CALIFORNIA LOS ANGELES2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
